HUVER · OUR JOURNEY
Built milestone
by milestone.
HUVER began with clinical discovery, built a medical multi-agent foundation, proved its performance, and expanded into U.S. healthcare. This is the detailed record behind the milestones on our homepage.
- FOUNDATION
Started with 20 healthcare professional interviews
Conducted structured field research to identify the clinical and operational problems worth solving.
- PROGRAM
Selected for Yonsei Graduate School of AI startup support
Secured an academic and technical environment for advancing the company’s early AI research.
- RESEARCH
Core medical multi-agent technology developed
Completed the core orchestration foundation and developed a precision antibiotic-prescribing workflow.
- RESEARCH · PROGRAM
Tertiary-hospital joint research and government startup support
Began joint research with a Korean tertiary hospital and was selected for the Ministry of SMEs and Startups Preliminary Startup Package.
- FOUNDATION
Selected for Yonsei Campus Town S-Cube
Established a dedicated research and product-development environment in the Yonsei University startup ecosystem.
- COMPANY
HUVER incorporated
Formally established the company and created the operating foundation for full-scale product and business development.
- PRODUCT
HUVA Chat development completed
Completed the first clinician-facing HUVA service and established a direct medical AI experience for healthcare professionals.
- PRODUCT · GLOBAL
Product MVP completed and global Step-Up program selection
Completed the DoctorHuv MVP and HU app design while joining Yonsei’s Global Startup Step-Up program.
- GLOBAL PROGRAMS
Selected for NVIDIA Inception, AWS Activate, and OpenAI Builder
Entered global technology programs supporting cloud infrastructure, model development, technical guidance, and market readiness.
- RESEARCH
Medical multi-agent research accepted for oral presentation
“A Hybrid Multi-Agent for Precision Antibiotic Prescribing” was accepted for presentation at the Korean Society of Infectious Diseases conference.
- PERFORMANCE
HUVAgent reaches #1 on HealthBench at approximately 70
Established the first top-ranked performance milestone and a baseline for subsequent model improvement.
- PRODUCT
HUVA v1.0 and HUVAgent Deep Search developed
Completed the first clinical-deployment solution and advanced evidence retrieval through HUVAgent Deep Search.
- PRODUCT · U.S.
Development begins on a U.S.-target product
Started building a product around U.S. clinic operations, payer workflows, and human-controlled execution while joining DHP Silicon Valley Bootcamp 2026.
- U.S. VALIDATION
Houston clinic and ASC pilot begins
Started field validation with a specialty clinic and ambulatory surgery center in Houston, Texas.
- U.S. EXPANSION
Silicon Valley investor and clinical conversations advance
Received new investor review opportunities, discussed a clinical proof of concept with Stanford Medicine, and participated in NVIDIA GTC.
- PROGRAM
Selected for KHIDI investment-attraction support
Connected with healthcare-focused investment institutions through the Korea Health Industry Development Institute program.
- U.S. NETWORK
Entered the Texas Medical Center ecosystem
Deepened access to Houston’s healthcare ecosystem for clinical validation, partnerships, and U.S. commercialization.
- PARTNERSHIP
Selected for NVIDIA NUP
Expanded access to NVIDIA’s technical ecosystem, expert support, and global AI network.
- INTEGRATED PRODUCT
HUVA Work + Chat integrated v1.0 completed
Completed the first integrated platform connecting organization-wide workflows with clinician-facing medical intelligence.
- PLANNED
HUVA Work v2.0 planned
The next release is planned for the second half of 2026, expanding connected clinical and operational workflows.
The next milestones are being built now.
See the products behind the journey or start a partnership conversation with HUVER.